Filter Results:
(990)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
Show Results For
- All HBS Web
(990)
- People (4)
- News (256)
- Research (615)
- Events (9)
- Multimedia (24)
- Faculty Publications (396)
- 01 Jun 2015
- News
Rebooting Europe
targeted effort to improve Ebola treatments resulted in development of an antiviral drug with potential to treat the early stages of the disease. Better research, Moedas says, also requires better support for researchers. At a gathering... View Details
- 01 Jun 2010
- News
Health IT at the Bedside
prescription from CVS and automatically check for any drug interactions. The hospital, like many community hospitals and doctors’ offices, did not have electronic records, but his office did. Would he ever go back to a paper prescription... View Details
- Profile
Max Seel
"that have unique bonding properties relevant to drug delivery." The other encounter became "the most life-changing experience" of his life: serving as a personal aide to a retired professor with Parkinson's disease.... View Details
- Web
Year in Review | Annual Report 2024
helping drug manufacturers produce life-saving biologics more efficiently, in order to deliver cheaper drugs to patients worldwide. Team: Narek Dshkhunyan, MBA 2024; Daniel Erdosy 2024 Crowd Favorite,... View Details
- 02 Sep 2015
- News
Voting for Optimism in Baltimore
problem that includes reducing the drug trade and its effect on homicides in the city while, at the same time, improving processes within the police department. When people can’t expect the police to do certain things, it causes the... View Details
- 01 Mar 2014
- News
Feedback
bulletin@hbs.edu. Write us a letter. This is your magazine. It needs your voice. Gene Williams, featured in the December 2013 HBS Alumni Bulletin Top Story The story of Gene Williams (MBA 1987) and his new drug development model hit a... View Details
Keywords: Health, Social Assistance
- 23 Apr 2014
- HBS Case
Are Electronic Cigarettes a Public Good or Health Hazard?
Drug Administration is proposing the first federal oversight of the product. The very fact users could control the amount of nicotine they ingested led to worry that e-cigarettes would cause smokers to take in more nicotine, rather than... View Details
- Web
Finalists | New Venture Competition
2024) Daniel Erdosy We help drug manufacturers produce life-saving biologics more efficiently, in order to deliver cheaper drugs to patients worldwide. SaveSpace Katharina Kelm (MBA 2024) Kelvin Kassis... View Details
- 12 Jan 2016
- First Look
January 12, 2016
November–December 2015 Operations Research Active Postmarketing Drug Surveillance for Multiple Adverse Events By: Goh, Joel, Margrét V. Bjarnadóttir, Mohsen Bayati, and Stefanos A. Zenios Abstract—Postmarketing View Details
Keywords: Carmen Nobel
- 01 Dec 2003
- News
Alumni Luminaries Discuss Careers, Values with HBS Students
leading-edge R&D, Novartis considers community outreach an essential part of its mission. It offers some drugs at a discount or free to needy patients; a new malaria therapy will be available at cost. Greylock, one of the country’s most... View Details
- 01 Mar 2007
- News
HBS Alums Help Jailhouse Entrepreneurs Go Straight
Like it or not, a drug dealer, for example, already knows a lot about what it takes to run a successful business. Teaching them passion is not something we have to do; what we teach them is how to go legit.” At HBS, several students are... View Details
- 18 Aug 2011
- Lessons from the Classroom
Business Plan Contest: 15 Years of Building Better Entrepreneurs
in 2001 with Alec Machiels (MBA '01) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug research. "A number of the scientists decided that being part of a... View Details
- 01 Jun 2011
- News
The Best-Laid Plans
failed companies. When Potentia Pharmaceuticals won the contest in 2001 with Alec Machiels (MBA 2001) at the helm, its plan hinged on a mechanism created by a team of Harvard and MIT scientists that used atomic force microscopy in drug... View Details
- 01 Mar 2009
- News
A New Approach to Health-Care Reform
companies, complete and accurate patient data would help in screening participants in drug trials and make it possible to track and troubleshoot unexpected problems that show up after a drug is introduced... View Details
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
experimentation and are triggering fundamental changes in R&D processes and performance in such fields as integrated circuit design, automotive development, and pharmaceutical drug discovery. Computer modeling and simulation, rapid... View Details
Keywords: by Wendy Guild
- 28 Apr 2016
- News
New Venture Competition Winners Announced
the $2,000 crowd favorite prize. It was a big night for big ideas in the health care field. In the student competition, Astraeus Technologies, a faster lung cancer screening, and UrSure, Inc., which is focused on HIV prevention drug... View Details
- Profile
Arjun Goyal
“marries a scientific eye for identifying precise populations in which therapies are effective, with a commercial appetite for successful drugs that need more time and money to prove their potential.” As part of a four-person clinical... View Details
- Profile
Hunter Goble
scientists in Harvard and MIT’s ecosystem. Through a self-matching process that Hunter describes as “speed dating,” he found two scientists from Boston’s Children’s Hospital developing “a novel drug delivery platform that increases the... View Details
- 27 Feb 2020
- Sharpening Your Skills
How Following Best Business Practices Can Improve Health Care
care, but there is another cost to be accounted for. Germany May Have the Answer for Reducing Drug PricesIn Germany, drugmakers must prove that a new medication’s benefits merit a higher price than existing drugs. Making Health Insurance... View Details
- 14 Apr 2014
- News
The Puzzle of Life
capitalize companies that may not make sense for venture funds but do make sense for smart angels who have more patience than most VCs." Among those companies: Rani Therapeutics, an early-stage venture focused on making injectable biological View Details